Unaudited Consolidated Balance Sheets - USD ($)	Mar. 31, 2016	Dec. 31, 2015
Current assets
Cash and cash equivalents	$ 239,214	$ 331,506
Accounts receivable	90,636	41,552
Other current assets	1,078	5,924
Total current assets	330,928	378,982
Patents, net of accumulated amortization of $104,978 and $57,500, respectively	2,271,253	2,318,731
Total assets	2,602,181	2,697,713
Current liabilities:
Accounts payable and accrued liabilities	262,108	69,884
Loans payable - third party	163,000	163,000
Purchase price of patents, current portion	1,000,000	1,000,000
Accrued interest - loans payable third party	236,688	232,613
Total current liabilities	1,661,796	1,465,497
Non-current liabilities
Loan payable - related party, net of unamortized discount and debt issuance costs of $672,082 and $687,754	633,484	586,563
Purchase price of patents, long term - net of unamortized discount of $141,607 and $173,769	858,393	826,231
Total liabilities	$ 3,153,673	$ 2,878,291
Stockholders' deficit:
Preferred stock - par value $.00003 - authorized 10,000,000 Shares - no shares issued and outstanding
Common stock, par value $0.00003; authorized 1,250,000,000 shares and 1,250,000,000 at March 31, 2016 and December 31, 2015, respectively; shares issued and outstanding 313,038,334 and 313,038,334, at March 31, 2016 and December 31, 2015, respectively	$ 9,391	$ 9,391
Additional paid-in capital	14,232,882	14,232,882
Accumulated deficit	(14,796,297)	(14,425,448)
Total Quest Patent Research Corporation deficit	(554,024)	(183,175)
Non-controlling interest in subsidiary	2,532	2,597
Total stockholders' deficit	(551,492)	(180,578)
Total liabilities and stockholders' deficit	$ 2,602,181	$ 2,697,713